Considerably more patients may benefit from effective antidiabetic drug (AlphaGalileo, 17 September 2012)

18 Sept 2012


A study using data from the Swedish national diabetes register published in BMJ Open assesses the risk-benefit profile of metformin in patients with type 2 diabetes and impaired kidney function.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story